Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Mescam, L."'
Autor:
Macagno N; CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, APHM, Timone, Marseille, France; Aix Marseille University, INSERM, MMG, Marseille, France. Electronic address: nicolas.macagno@ap-hm.fr., Kervarrec T; CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; 'Biologie des infections à polyomavirus' team, UMR INRA ISP 1282, Université de Tours, Tours, France., Thanguturi S; Department of Pathology, « Institut d'histopathologie, Tours, France., Sohier P; Department of Pathology, Hôpital Cochin, AP-HP. Centre-Université Paris Cité, Paris, France., Pissaloux D; Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France., Mescam L; Department of Biopathology, Paoli-Calmettes Institute, Marseille, France., Jullie ML; Department of Pathology, University Hospital of Bordeaux, Bordeaux, France., Frouin E; Department of Pathology, University Hospital of Poitiers, University of Poitiers, LITEC, Poitiers, France., Osio A; National Center of Dermatopathology, Paris-la Roquette, Ivry, France; Department of Pathology, HCL Lyon-Sud Hospital, Lyon, France., Faisant M; Cypath, Villeurbanne, France., Le Loarer F; Department of Biopathology, Bergonié Institute, Bordeaux, France; Bordeaux Institute of Oncology, BRIC U1312, INSERM, Université de Bordeaux, Institut Bergonié, Bordeaux, France., Cribier B; Department of Dermatology, University of Strasbourg, Strasbourg, France., Calonje E; Department of Dermatopathology, St John's institute of Dermatology, Guy's and St Thomas' NHS trust, London, United Kingdom., Luna EVE; Department of Dermatopathology, St John's institute of Dermatology, Guy's and St Thomas' NHS trust, London, United Kingdom., Massi D; Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy., Goto K; Department of Diagnostic Pathology, Faculty of Medicine, Oita, Japan., Nishida H; Department of Diagnostic Pathology, Faculty of Medicine, Oita, Japan., Paindavoine S; Department of Biopathology, Centre Léon Bérard, Lyon, France., Houlier A; Department of Biopathology, Centre Léon Bérard, Lyon, France., Tantot J; Department of Pathology, HCL Lyon-Sud Hospital, Lyon, France., Benzerdjeb N; Department of Pathology, HCL Lyon-Sud Hospital, Lyon, France., Tirode F; Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France., De la Fouchardière A; Department of Biopathology, Centre Léon Bérard, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France., Battistella M; CARADERM, French Network of Rare Skin Cancers, Lille, France; Department of Pathology, AP-HP Hospital Saint-Louis, INSERM U976, Université Paris Cité, Paris, France.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Mar; Vol. 37 (3), pp. 100430. Date of Electronic Publication: 2024 Jan 23.
Autor:
Noel R; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Zemmour C; Department of Clinical Research and Innovation - Biostatistics & Methodology Unit, Marseille, France.; Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France., Montes de Oca C; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Belmecheri N; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Aurran-Schleinitz T; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Coso D; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Lopez Almeida L; Department of Clinical Research and Innovation - Sponsoring Unit, Institut Paoli-Calmettes, Marseille, France., Mescam L; Department of Pathology, Institut Paoli-Calmettes, Marseille, France., Vey N; Department of Hematology, Institut Paoli-Calmettes, Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France., Bladé JS; Department of Oncology and Hematology, Sainte Anne Military Hospital, Toulon, France., Slama B; Department of Hematology, Centre Hospitalier Raoul Follereau, Avignon, France., Bouabdallah R; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Schiano de Colella JM; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Publikováno v:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2207948.
Autor:
Boudin L; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., de Nonneville A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Finetti P; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., Mescam L; French Sarcoma Group, Lyon, France.; Department of Pathology, Institut Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009, Marseille, France., Le Cesne A; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Italiano A; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Institut Bergonie, Bordeaux, France., Blay JY; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Centre Léon Bérard, UNICANCER &, Université Claude Bernard Lyon I, Lyon, France., Birnbaum D; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., Mamessier E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., Bertucci F; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France. bertuccif@ipc.unicancer.fr.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. bertuccif@ipc.unicancer.fr.; French Sarcoma Group, Lyon, France. bertuccif@ipc.unicancer.fr.
Publikováno v:
Journal of translational medicine [J Transl Med] 2022 Oct 11; Vol. 20 (1), pp. 464. Date of Electronic Publication: 2022 Oct 11.
Autor:
Laurent C; Department of Pathology, Cancer University Institute of Toulouse, CHU de Toulouse.; INSERM, U1037, Research Center In Cancer of Toulouse, laboratoire d'excellence TOUCAN, Toulouse., Syrykh C; Department of Pathology, Cancer University Institute of Toulouse, CHU de Toulouse., Hamon M; Departments of Pathology., Adélaïde J; Departments of Predictive Oncology., Guille A; Departments of Predictive Oncology., Escudié F; Department of Pathology, Cancer University Institute of Toulouse, CHU de Toulouse., Jalowicki G; Department of Pathology, Cancer University Institute of Toulouse, CHU de Toulouse., Fina F; Department of Pathology and Neuropathology, APHM, CHU Timone, Marseille., Bardet A; Pathology and Tumor Immunology, Institut Paoli-Calmettes, Research Center in Cancer of Marseille, INSERM U1068, CNRS UMR7258, Aix-Marseille University, UM105., Mescam L; Pathology and Tumor Immunology, Institut Paoli-Calmettes, Research Center in Cancer of Marseille, INSERM U1068, CNRS UMR7258, Aix-Marseille University, UM105., Molina TJ; Department of Pathology, Necker Hospital, Paris., Dartigues P; Department of Pathology, Institut of Gustave Roussy., Parrens M; Department of Pathology, CHU de Bordeaux, INSERM U1053, Bordeaux University, Bordeaux., Sujobert P; Laboratory of Hematology, Centre Hospitalier Lyon Sud, Cancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Lyon, France., Besson C; Hematology, André Mignot Hospital, Versailles.; Paris-Saclay University, UVSQ, Inserm, Équipe 'Exposome et Hérédité,' CESP, Villejuif., Birnbaum D; Departments of Predictive Oncology., Xerri L; Pathology and Tumor Immunology, Institut Paoli-Calmettes, Research Center in Cancer of Marseille, INSERM U1068, CNRS UMR7258, Aix-Marseille University, UM105.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2022 Jun 01; Vol. 46 (6), pp. 742-753. Date of Electronic Publication: 2021 Nov 18.
Autor:
Bertucci F; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France bertuccif@ipc.unicancer.fr.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; French Sarcoma Group, Lyon, France., Niziers V; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France.; Department of Surgery, Institut Paoli-Calmettes, Marseille, France., de Nonneville A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Finetti P; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., Mescam L; French Sarcoma Group, Lyon, France.; Department of Pathology, Institut Paoli-Calmettes, Marseille, France., Mir O; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Italiano A; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Institut Bergonie, Bordeaux, France., Le Cesne A; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Blay JY; French Sarcoma Group, Lyon, France.; Department of Medical Oncology, Centre Leon Berard, Lyon, France., Ceccarelli M; DIETI, University of Naples Federico II Faculty of Engineering, Naples, Italy., Bedognetti D; Cancer Research, Sidra Medicine, Doha, Qatar.; Department of Internal Medicine and Medical Specialties, University of Genova, Genova, Italy., Birnbaum D; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France., Mamessier E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille Université, INSERM UMR1068, CNRS UMR725, Marseille, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Autor:
Bertucci F; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France. bertuccif@ipc.unicancer.fr.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. bertuccif@ipc.unicancer.fr., Gonçalves A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Guille A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Adelaïde J; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Garnier S; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Carbuccia N; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Billon E; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Finetti P; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France., Monneur A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Pécheux C; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France., Khran M; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.; Aix-Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France., Brunelle S; Department of Imaging, Institut Paoli-Calmettes, Marseille, France., Mescam L; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Poizat F; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Charafe-Jauffret E; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France., Lambaudie E; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France., Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Extra JM; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Mamessier E; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France., Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, UMR981 Inserm, Villejuif, France.; Paris Sud University, Orsay, France., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France., Birnbaum D; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Chaffanet M; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Publikováno v:
Genome medicine [Genome Med] 2021 May 18; Vol. 13 (1), pp. 87. Date of Electronic Publication: 2021 May 18.
Autor:
de Pinieux G; Department of pathology, CHU de Tours, Tours, France., Karanian M; Department of Biopathology, Centre Léon Bérard, Lyon, France., Le Loarer F; Department of Biopathology, Institut Bergonié, Bordeaux, France., Le Guellec S; Department of Biopathology, Institut Claudius Regaud et Institut Universitaire du Cancer de Toulouse-Oncopôle, Toulouse, France., Chabaud S; Department of Biopathology, Centre Léon Bérard, Lyon, France., Terrier P; Department of Biopathology, Gustave Roussy, Villejuif, France., Bouvier C; Department of pathology, La Timone University Hospital, Marseille, France., Batistella M; Pathology Department, Saint-Louis Hospital, AP-HP, Université de Paris, Paris, France., Neuville A; Department of Biopathology, Institut Bergonié, Bordeaux, France., Robin YM; Pôle de Biologie-Pathologie-Génétique Centre Oscar Lambret, & Institut de Pathologie entre Oscar Lambret & CHU Lille, Lille, France., Emile JF; Department of Biopathology, Hopital Ambroise Paré, Boulogne, France., Moreau A; Department of Pathology, Department of Orthopedy CHU Nantes, Nantes, France., Larousserie F; Department of Biopathology, Hôpital Cochin-Saint-Vincent de Paul, Paris, France., Leroux A; Department of Biopathology, Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre-lès-Nancy, France., Stock N; Department of Biopathology, Eugene Marquis Comprehensive Cancer Center & CHU Rennes, Rennes, France., Lae M; Department of Biopathology, Eugene Marquis Comprehensive Cancer Center & CHU Rennes, Rennes, France.; Department of Biopathology, Institut Curie, Paris, France., Collin F; Department of Biopathology, Centre Georges François Leclerc, Dijon, France., Weinbreck N; Medipath, Frejus, France., Aubert S; Pôle de Biologie-Pathologie-Génétique Centre Oscar Lambret, & Institut de Pathologie entre Oscar Lambret & CHU Lille, Lille, France., Mishellany F; Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France., Charon-Barra C; Department of Biopathology, Centre Georges François Leclerc, Dijon, France., Croce S; Department of Biopathology, Institut Bergonié, Bordeaux, France., Doucet L; Department of pathology, CHRU Brest, Brest, France., Quintin-Rouet I; Department of pathology, CHRU Brest, Brest, France., Chateau MC; Department of Biopathology, Institut de Cancérologie de Montpellier & CHU Montpellier, Montpellier, France., Bazille C; Department of Biopathology, Centre Francois Baclesse, Caen, France., Valo I; Department of Pathology, Institut de Cancerologie de l'Ouest, Angers, France., Chetaille B; Medipath, Frejus, France., Ortonne N; Department of Biopathology, Hopital Henri Mondor, Creteil, France., Brouchet A; Department of Biopathology, Institut Claudius Regaud et Institut Universitaire du Cancer de Toulouse-Oncopôle, Toulouse, France., Rochaix P; Department of Biopathology, Institut Claudius Regaud et Institut Universitaire du Cancer de Toulouse-Oncopôle, Toulouse, France., Demuret A; Department of pathology, CHU de Tours, Tours, France., Ghnassia JP; Department of Biopathology, Centre Paul Strauss, Strasbourg, France., Mescam L; Department of Biopathology, Institut Paoli Calmettes, Marseille, France., Macagno N; Department of pathology, La Timone University Hospital, Marseille, France., Birtwisle-Peyrottes I; Department of Biopathology, Centre Antoine-Lacassagne, Nice, France., Delfour C; Department of Biopathology, Institut de Cancérologie de Montpellier & CHU Montpellier, Montpellier, France., Angot E; Department of Biopathology, Eugene Marquis Comprehensive Cancer Center & CHU Rennes, Rennes, France., Pommepuy I; Department of Biopathology, CHU Limoges, Limoges, France., Ranchere D; Department of Biopathology, Centre Léon Bérard, Lyon, France., Chemin-Airiau C; Department of Biopathology, Centre Léon Bérard, Lyon, France., Jean-Denis M; Department of Biopathology, Centre Léon Bérard, Lyon, France., Fayet Y; Department of Biopathology, Centre Léon Bérard, Lyon, France., Courrèges JB; Department of Biopathology, Institut Bergonié, Bordeaux, France., Mesli N; Department of Biopathology, Institut Bergonié, Bordeaux, France., Berchoud J; Department of Pathology, Department of Orthopedy CHU Nantes, Nantes, France., Toulmonde M; Department of Biopathology, Institut Bergonié, Bordeaux, France., Italiano A; Department of Biopathology, Institut Bergonié, Bordeaux, France., Le Cesne A; Department of Biopathology, Centre Léon Bérard, Lyon, France., Penel N; Pôle de Biologie-Pathologie-Génétique Centre Oscar Lambret, & Institut de Pathologie entre Oscar Lambret & CHU Lille, Lille, France., Ducimetiere F; Department of Biopathology, Centre Léon Bérard, Lyon, France., Gouin F; Department of Biopathology, Centre Léon Bérard, Lyon, France., Coindre JM; Department of Biopathology, Institut Bergonié, Bordeaux, France., Blay JY; Department of Biopathology, Centre Léon Bérard, Lyon, France.; Department of Medicine of Centre Leon Berard, University Claude Bernard Lyon I, Lyon, France.; Headquarters, Unicancer, Paris, France.
Publikováno v:
PloS one [PLoS One] 2021 Feb 25; Vol. 16 (2), pp. e0246958. Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021).
Autor:
Mescam L; Department of Biopathology, Institut Paoli Calmettes, Marseille, France., Camus V; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1249, Centre Henri Becquerel, Rouen, France., Schiano JM; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Adélaïde J; Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7258, Aix-Marseille University, UM 105, Marseille, France., Picquenot JM; Department of Pathology, Centre Henri Becquerel, Rouen, France., Guille A; Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7258, Aix-Marseille University, UM 105, Marseille, France., Bannier M; Department of Surgical Oncology, Institut Paoli Calmettes, Marseille, France., Ruminy P; INSERM U1249, Centre Henri Becquerel, Rouen, France., Viailly PJ; INSERM U1249, Centre Henri Becquerel, Rouen, France., Jardin F; Department of Hematology, Centre Henri Becquerel, Rouen, France.; INSERM U1249, Centre Henri Becquerel, Rouen, France., Bouabdallah R; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Brenot-Rossi I; Department of Nuclear Imaging, Institut Paoli Calmettes, Marseille, France., Bohers E; INSERM U1249, Centre Henri Becquerel, Rouen, France., Robe C; Department of Pathology, INSERM U955, Hôpital Henri Mondor, Créteil, France., Laurent C; Department of Pathology, CHU Toulouse, IUCT Oncopole, INSERM, UMR 1037 Centre de Recherche en Cancerologie de Toulouse, Laboratoire D'Excellence Toulouse Cancer (TOUCAN), Paul Sabatier University Toulouse III, Toulouse, France., Birnbaum D; Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7258, Aix-Marseille University, UM 105, Marseille, France., Wotherspoon A; Department of Pathology, Royal Marsden Hospital, London, United Kingdom; and., Gaulard P; Department of Pathology, INSERM U955, Hôpital Henri Mondor, Créteil, France., Xerri L; Department of Biopathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR 7258, Aix-Marseille University, UM105, Marseille, France.
Publikováno v:
Blood [Blood] 2020 May 28; Vol. 135 (22), pp. 2004-2009.
Autor:
Houvenaeghel, Gilles1 (AUTHOR) houvenaeghelg@ipc.unicancer.fr, Classe, Jean-Marc2 (AUTHOR) jean-marc.classe@ico.unicancer.fr, Chauvet, Marie-Pierre3 (AUTHOR) mp-chauvet@o-lambret.fr, Colombo, Pierre-Emmanuel4 (AUTHOR) pierre-emmanuel.colombo@icm.unicancer.fr, Jouve, Eva5 (AUTHOR) jouve.eva@iuct-oncopole.fr, Reyal, Fabien6 (AUTHOR) fabien.reyal@curie.fr, Daraï, Emile7 (AUTHOR) emile.darai@tnn.aphp.fr, Rouzier, Roman8 (AUTHOR) r.rouzier@baclesse.unicancer.fr, Faure-Virelizier, Christelle9 (AUTHOR) christelle.faure@lyon.unicancer.fr, Gimbergues, Pierre10 (AUTHOR) pierre.gimbergues@cjp.fr, Coutant, Charles11 (AUTHOR) ccoutant@cgfl.fr, Mazouni, Chafika12 (AUTHOR) mazouni@igr.fr, Azuar, Anne-Sophie13 (AUTHOR) as-azuar@chgrasse.fr, Martino, Marc14 (AUTHOR) martinom@ipc.unicancer.fr, Bouteille, Catherine15 (AUTHOR) bouteillec@ipc.unicancer.fr, Cohen, Monique15 (AUTHOR) cohenm@ipc.unicancer.fr, de Nonneville, Alexandre16 (AUTHOR) houvenaeghelg@ipc.unicancer.fr
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 19, p3317. 15p.
Autor:
Laurent C; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Centre de Recherche en Cancerologie de Toulouse, INSERM, UMR1037 laboratoire d'excellence Toulouse Cancer (Labex TOUCAN), Paul Sabatier University Toulouse III, Toulouse, France., Nicolae A; Pathology and Cytology Department, Centre Hospitalier Universitaire Hautepierre, Strasbourg, France.; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France., Laurent C; Institut Carnot CALYM, Lymphoma Academic Research Organisation, Institut Carnot, Pierre-Bénite, France., Le Bras F; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France., Haioun C; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France., Fataccioli V; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Department of Pathology, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France., Amara N; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Adélaïde J; Department of Predictive Oncology, Institut Paoli-Calmettes, and.; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France., Guille A; Department of Predictive Oncology, Institut Paoli-Calmettes, and.; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France., Schiano JM; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Tesson B; Institut Carnot CALYM, Lymphoma Academic Research Organisation, Institut Carnot, Pierre-Bénite, France., Traverse-Glehen A; Pathology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Chenard MP; Pathology and Cytology Department, Centre Hospitalier Universitaire Hautepierre, Strasbourg, France., Mescam L; Department of Bio-Pathology Institut Paoli-Calmettes, Marseille, France., Moreau A; Pathology and Cytology Department, Centre Hospitalier Hôtel Dieu, Nantes, France., Chassagne-Clement C; Department of Bio-Pathology Pathology and Cytology Department, Centre Léon Bérard, Lyon, France., Somja J; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Liège, Liège, Belgium., Escudié F; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., André M; Department of Hematology, Centre Hospitalo-Universitaire UCLouvain Namur, Yvoir, Belgium., Martin N; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France., Lacroix L; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France., Lemonnier F; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Lymphoid Malignancies Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Créteil, France., Hamy AS; Curie Institute, Residual Tumour and Response to Treatment Laboratory, RT2Lab, INSERM, U 932 Immunity and Cancer, Paris, France., Reyal F; Curie Institute, Residual Tumour and Response to Treatment Laboratory, RT2Lab, INSERM, U 932 Immunity and Cancer, Paris, France.; Curie Institute, Department of Surgery, Paris Descartes University, Paris, France., Bannier M; Department of Surgery, Institut Paoli-Calmettes, Marseille, France., Oberic L; Hematology Department and., Prade N; Laboratory of Hematology, Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire de Cancérologie de Toulouse, Toulouse, France; and., Frénois FX; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Beldi-Ferchiou A; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Department of Immunobiology and Haematobiology, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France., Delfau-Larue MH; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Department of Immunobiology and Haematobiology, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France., Bouabdallah R; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Birnbaum D; Department of Predictive Oncology, Institut Paoli-Calmettes, and.; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France., Brousset P; Pathology and Cytology Department, Centre Hospitalo-Universitaire de Toulouse,Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.; Centre de Recherche en Cancerologie de Toulouse, INSERM, UMR1037 laboratoire d'excellence Toulouse Cancer (Labex TOUCAN), Paul Sabatier University Toulouse III, Toulouse, France., Xerri L; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR7258, Aix-Marseille University, UM105, Marseille, France.; Department of Bio-Pathology Institut Paoli-Calmettes, Marseille, France., Gaulard P; Institut Mondor de Recherche Biomédicale, INSERM U955, Université Paris-Est, Créteil, France.; Department of Pathology, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.
Publikováno v:
Blood [Blood] 2020 Jan 30; Vol. 135 (5), pp. 360-370.